World News: 11:05 GMT Thursday 14th June 2018. [Nightstar Therapeutics via Globe Newswire via SPi World News]
WALTHAM Mass and LONDON June 14 2018 GLOBE NEWSWIRE) -- Nightstar Therapeutics plc NASDAQNITE a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced that the US Food and Drug Adm inistra...
Globe Newswire: 11:05 GMT Thursday 14th June 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.